JAG2 and neoplasm: When the Notch pathway is suppressed by an inhibitor, such as a γ‐secretase inhibitor, treatment with an anti‐JAG2 antibody results in the attenuation of tumor growth and augmentation of cytotoxic roles of CD8+ T cells.16